A cost-effectiveness analysis of vaccinating older adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) compared to no vaccination, the 13-valent pneumococcal conjugate vaccine (PCV13), or PCV13 followed by PPV23 in Colombia

Polysaccharide Vaccine ◽

VACCINATING OLDER ADULTS IN JAPAN WITH 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) COMPARED TO 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) OR NO VACCINATION (NOVAC): A COST-EFFECTIVENESS ANALYSIS

10.26226/morressier.5731f0d6d462b8029237fcb3 ◽

2016 ◽

Author(s):

Yiling Jiang

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Polysaccharide Vaccine ◽

VACCINATING OLDER ADULTS IN KOREA WITH 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) COMPARED TO 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) OR NO VACCINATION (NOVAC): A COST-EFFECTIVENESS ANALYSIS

10.26226/morressier.5731f0d6d462b8029237fcb8 ◽

2016 ◽

Cited By ~ 1

Author(s):

Yiling Jiang

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Polysaccharide Vaccine ◽

A Cost-Effectiveness Analysis of Vaccinating The Elderly with The 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23) Compared To No Vaccination, The 13-Valent Pneumococcal Conjugate Vaccine (Pcv13), or Pcv13 Followed by Ppv23 in Brazil

Value in Health ◽

10.1016/j.jval.2017.08.2909 ◽

2017 ◽

Vol 20 (9) ◽

pp. A930 ◽

Cited By ~ 1

Author(s):

Y Jiang ◽

X Yang ◽

T Petigara ◽

L Chabrol Haas ◽

J Graham

Keyword(s):

Cost Effectiveness ◽

Conjugate Vaccine ◽

The Elderly ◽

Polysaccharide Vaccine ◽

CE1 The Cost-Effectiveness Analysis of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Taiwan

Value in Health ◽

10.1016/j.jval.2012.08.003 ◽

2012 ◽

Vol 15 (7) ◽

pp. A602 ◽

Cited By ~ 1

Author(s):

D.B.C. Wu ◽

C.J. Chang ◽

L. Chien ◽

H.C.H. Fang ◽

C.S. Roberts

Keyword(s):

Cost Effectiveness ◽

Conjugate Vaccine ◽

Polysaccharide Vaccine ◽

Effectiveness Analysis ◽

The Cost

Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2018.1456602 ◽

2018 ◽

Vol 14 (8) ◽

pp. 1914-1922 ◽

Cited By ~ 4

Author(s):

Min-Joo Choi ◽

Shin-On Kang ◽

Jin-Jeong Oh ◽

Seong-Beom Park ◽

Min-Ja Kim ◽

...

Keyword(s):

Cost Effectiveness ◽

South Korea ◽

Conjugate Vaccine ◽

Adult Population ◽

Polysaccharide Vaccine ◽

Cost-Effectiveness Analysis Of Sequential Vaccination Of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) And 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) On Adult Population In South Korea

Value in Health ◽

10.1016/j.jval.2017.08.2308 ◽

2017 ◽

Vol 20 (9) ◽

pp. A788

Author(s):

D Park ◽

S Kang

Keyword(s):

Cost Effectiveness ◽

South Korea ◽

Conjugate Vaccine ◽

Adult Population ◽

Polysaccharide Vaccine ◽

A cost-effectiveness analysis of revaccination and catch-up strategies with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in older adults in Japan

Journal of Medical Economics ◽

10.1080/13696998.2018.1465272 ◽

2018 ◽

Vol 21 (7) ◽

pp. 687-697 ◽

Cited By ~ 4

Author(s):

Yiling Jiang ◽

Xiaoqin Yang ◽

Kazuko Taniguchi ◽

Tanaz Petigara ◽

Machiko Abe

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Polysaccharide Vaccine ◽

Effectiveness Analysis ◽

Catch Up

Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia

BMC Infectious Diseases ◽

10.1186/1471-2334-14-172 ◽

2014 ◽

Vol 14 (1) ◽

Cited By ~ 13

Author(s):

Jaime E Ordóñez ◽

John J Orozco

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

PIN43 - A COST-EFFECTIVENESS ANALYSIS OF REVACCINATING OLDER ADULTS WITH THE 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) COMPARED TO VACCINATING WITH A SINGLE DOSE OF PPV23 IN THE UNITED KINGDOM (UK)

Value in Health ◽

10.1016/j.jval.2018.09.1362 ◽

2018 ◽

Vol 21 ◽

pp. S228

Author(s):

Y. Jiang ◽

X. Yang ◽

S. Mahajan ◽

R. Gupta ◽

I.R. Matthews

Keyword(s):

Older Adults ◽

United Kingdom ◽

Single Dose ◽

Cost Effectiveness ◽

Polysaccharide Vaccine ◽

The United Kingdom ◽

COST-EFFECTIVENESS OF A PNEUMOCOCCAL SEQUENTIAL IMMUNIZATION WITH 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADDITION TO 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE TO IMMUNOCOMPETENT OLDER ADULTS IN SPAIN

10.26226/morressier.5731f0d6d462b8029237fc7f ◽

2016 ◽

Author(s):

Sergio Cedillo

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Polysaccharide Vaccine

Polysaccharide Vaccine ◽